Mohammad R. Seyedsayamdost,Bethany K. Okada,Anran Li
申请号：
US16824968
公开号：
US20200297669A1
申请日:
2020.03.20
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed are methods for using guanfacine, an analog or derivative of guanfacine, or a pharmaceutically acceptable salt thereof, to reduce the virulence of a bacterial pathogen. When treating a patient, the method generally involves administering to the patient a therapeutically effective dose of guanfacine, an analog or derivative of guanfacine, or a pharmaceutically acceptable salt thereof. An alternative method involves contacting the bacterial pathogen with guanfacine, an analog or derivative of guanfacine, or a pharmaceutically acceptable salt thereof.
